Marlborough biotech firm Advanced Cell Technology said it has picked up $30 million in capital through a common stock purchase agreement with a Chicago-based investment firm.
The deal, with Lincoln Park Capital Fund, gives Advanced Cell (ACT) another funding option to grow its business “without creating complications in our capital structure” as the company pushes for long-term, “fundamental-based institutional capital.” interim president, CEO and COO Ted Myles said in a statement.
The federal government has given the go-ahead for a Marlborough company to market its wearable robotic exoskeleton for individuals with spinal cord injuries, the company said.
A company specializing in home furnishings for real estate staging purposes will occupy the building at 321 Central St. in Hudson following a $2.1-million sale on June 18, according to Wayland-based R.W. Holmes Realty.
Advanced Cell Technology (ACT), a Marlborough-based biotechnology firm that is developing stem cell treatments for diseases causing blindness, has hired an industry veteran as its new president and CEO.
St. Mary's Credit Union has bought a Marlborough building for $7.5 million to serve as the company's new headquarters.
The credit union plans to move its 70 corporate employees into a 60,500-square-foot building at 46 Lizotte Drive by the end of the year, said Tony Battista, vice president of marketing. This will be the first time St. Mary's owns a standalone headquarters building, according to Battista.
Family relationships can be complicated. But in some cases, those blood relationships can be tested and even strained when there's a family business involved that needs caring and nurturing.